prices

Timophey Nizhegorodtsev: drug substitutability help prevent bid-rigging
Head of FAS Department for Control over Social Sphere and Trade, Timophey Nizhegorodtsev reviewed large-scale changes in the pharmaceutical sector in the past ten years
more
FAS opened a case against “Novartis Pharma” Ltd.
The company is suspected of fixing monopolistically high price for “Tyverb” medicinal drug
more
FAS exposed excessive prices for preventive-and-immune drug
The third stage of comparative analysis of drug prices exposed pricing violations for 7 medicines in Russia
more
FAS managed to decrease 239 prices on the drugs for treating HIV, tuberculosis, hepatitis B and C
The minimum saving of budgetary funds from reducing prices will reach over 63 million RUB for the Ministry of health Care for HIV-treatment drugs
more